Clyde Mandy D. 4

Accession 0001567619-19-007658

CIK 0001505497other

View on SEC.gov Company Profile

Filed

Mar 25, 8:00 PM ET

Accepted

Mar 26, 5:15 PM ET

Size

54.5 KB

Accession

0001567619-19-007658

Insider Transaction Report

Form 4

Period: 2019-03-25

BioRestorative Therapies, Inc.BRTX

Clark Mandy D.

VP of Operations

Transactions

Award
Stock Option
2019-03-25+300→ 300 total
Exercise: $0.75Exp: 2021-04-20→ Common Stock (300 underlying)
Award
Stock Option
2019-03-25+4,000→ 4,000 total
Exercise: $0.75Exp: 2023-10-04→ Common Stock (4,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−2,500→ 0 total
Exercise: $4.70Exp: 2022-12-07→ Common Stock (2,500 underlying)
Disposition to Issuer
Stock Option
2019-03-25−4,000→ 0 total
Exercise: $4.70Exp: 2023-10-04→ Common Stock (4,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−6,250→ 0 total
Exercise: $4.70Exp: 2024-02-18→ Common Stock (6,250 underlying)
Award
Stock Option
2019-03-25+25,500→ 25,500 total
Exercise: $0.75Exp: 2025-09-04→ Common Stock (25,500 underlying)
Award
Stock Option
2019-03-25+20,000→ 20,000 total
Exercise: $0.75Exp: 2027-08-10→ Common Stock (20,000 underlying)
Award
Stock Option
2019-03-25+6,250→ 6,250 total
Exercise: $0.75Exp: 2024-02-18→ Common Stock (6,250 underlying)
Disposition to Issuer
Stock Option
2019-03-25−40,000→ 0 total
Exercise: $3.73Exp: 2026-06-10→ Common Stock (40,000 underlying)
Award
Stock Option
2019-03-25+30,000→ 30,000 total
Exercise: $0.75Exp: 2027-07-12→ Common Stock (30,000 underlying)
Award
Stock Option
2019-03-25+50,000→ 50,000 total
Exercise: $0.75Exp: 2028-10-29→ Common Stock (50,000 underlying)
Award
Stock Option
2019-03-25+4,000→ 4,000 total
Exercise: $0.75From: 2010-12-15Exp: 2020-12-14→ Common Stock (4,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−300→ 0 total
Exercise: $4.70Exp: 2021-04-20→ Common Stock (300 underlying)
Disposition to Issuer
Stock Option
2019-03-25−1,500→ 0 total
Exercise: $4.70Exp: 2022-02-09→ Common Stock (1,500 underlying)
Award
Stock Option
2019-03-25+1,500→ 1,500 total
Exercise: $0.75Exp: 2022-02-09→ Common Stock (1,500 underlying)
Award
Stock Option
2019-03-25+2,500→ 2,500 total
Exercise: $0.75Exp: 2022-12-07→ Common Stock (2,500 underlying)
Award
Stock Option
2019-03-25+10,000→ 10,000 total
Exercise: $0.75Exp: 2024-10-23→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−30,000→ 0 total
Exercise: $2.80Exp: 2027-07-12→ Common Stock (30,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−50,000→ 0 total
Exercise: $1.23Exp: 2028-10-29→ Common Stock (50,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−4,000→ 0 total
Exercise: $4.70From: 2010-12-15Exp: 2020-12-14→ Common Stock (4,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−10,000→ 0 total
Exercise: $4.70Exp: 2024-10-23→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−25,500→ 0 total
Exercise: $4.70Exp: 2025-09-04→ Common Stock (25,500 underlying)
Award
Stock Option
2019-03-25+40,000→ 40,000 total
Exercise: $0.75Exp: 2026-06-10→ Common Stock (40,000 underlying)
Disposition to Issuer
Stock Option
2019-03-25−20,000→ 0 total
Exercise: $3.35Exp: 2027-08-10→ Common Stock (20,000 underlying)

Footnotes (12)

[F1]The option is exercisable to the extent of 100 shares on each of April 21, 2011, April 21, 2012 and April 21, 2013.
[F10]The option is exercisable to the extent of 6,667 shares on each of August 10, 2018 and August 10, 2019, and 6,666 shares on August 10, 2020.
[F11]The option is exercisable to the extent of 16,667 shares on each of October 29, 2019 and October 29, 2020, and 16,666 shares on October 29, 2021.
[F12]The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price.
[F2]The option is exercisable to the extent of 750 shares on each of February 10, 2012 and February 10, 2013.
[F3]The option is exercisable to the extent of 1,250 shares on each of December 7, 2012 and December 7, 2013.
[F4]The option is exercisable to the extent of 2,000 shares on each of October 4, 2013 and October 4, 2014.
[F5]The option is exercisable to the extent of 2,084 shares on February 18, 2014, and 2,083 shares on each of February 18, 2015 and February 18, 2016.
[F6]The option is exercisable to the extent of 3,334 shares on October 23, 2015 and 3,333 shares on each of October 23, 2016 and October 23, 2017.
[F7]The option is exercisable to the extent of 8,500 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018.
[F8]The option is exercisable to the extent of 13,334 shares on June 10, 2017 and 13,333 shares on each of June 10, 2018 and June 10, 2019.
[F9]The option is exercisable to the extent of 10,000 shares on each of July 12, 2018, July 12, 2019 and July 12, 2020.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

BioRestorative Therapies, Inc.

CIK 0001505497

→

Entity typeother

Related Parties

filerCIK 0001527239

Filing Metadata

Form type: 4
Filed: Mar 25, 8:00 PM ET
Accepted: Mar 26, 5:15 PM ET
Size: 54.5 KB

View on SEC.gov